0001415889-24-015760.txt : 20240606
0001415889-24-015760.hdr.sgml : 20240606
20240606162540
ACCESSION NUMBER: 0001415889-24-015760
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240604
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ives Jeffrey L.
CENTRAL INDEX KEY: 0001614096
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 241025400
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 1 PARROTT DRIVE
CITY: SHELTON
STATE: CT
ZIP: 06484
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 ATLANTIC STREET, SUITE 500
CITY: STAMFORD
STATE: CT
ZIP: 06901
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 400 ATLANTIC STREET, SUITE 500
CITY: STAMFORD
STATE: CT
ZIP: 06901
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
4
1
form4-06062024_080636.xml
X0508
4
2024-06-04
0001346830
Cara Therapeutics, Inc.
CARA
0001614096
Ives Jeffrey L.
C/O CARA THERAPEUTICS, INC.
400 ATLANTIC STREET, SUITE 500
STAMFORD
CT
06901
true
false
false
false
0
Common Stock
2024-06-04
4
A
0
150647
0
A
198485
D
Stock Option (Right to Buy)
0.664
2024-06-04
4
A
0
195000
0
A
2034-06-04
Common Stock
195000
195000
D
Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
/s/ Darren DeStefano, Attorney-in-Fact
2024-06-06